Vertex Pharmaceuticals Just Made a Major Move: Is the Stock a Buy?
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
Determine whether a 6-month or 12-month fund is right for you by assessing income stability, essential expenses, and personal risk appetite.
15,911 articlesVertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
Oil prices surge as tensions around Iran intensify and the ceasefire appears cracking. Traders weigh supply disruptio...
The 2026 IPO boom is broadening beyond AI megadeals as mid-cap and overlooked sectors attract new capital. A busy sec...
Oklo faced a sharp pullback in early 2026 as sector bets cooled and financing moves pressured shares. This guide brea...
In a volatile market, the dividend growth approach that emphasizes rising payouts over big yields is drawing attentio...
A surge in triple-leveraged ETFs has driven notional exposure to about $500 billion, intensifying daily volatility an...
New research finds america pays workers just a fraction of the country’s wealth, a share that trails most OECD peers ...
The U.S. government moved 3,940 BTC valued at about $244 million and 30,014 ETH worth roughly $53 million to Coinbase...
Apple sidesteps the AI capex race, prioritizing software and on-device AI. Analysts see a bigger iPhone upgrade cycle...
If Rivian hits the sweet spot with the R2, the stock story could change in meaningful ways. This guide breaks down wh...
House Republicans rolled out a $95 billion budget blueprint aimed at defense, farming support, and stricter voter reg...
Thai and Taiwanese AI stock funds are gaining traction as Korea’s AI boom extends across Asia. This report examines w...